Literature DB >> 25118551

Acute intermittent porphyria presenting as progressive muscular atrophy in a young black man.

C H Albertyn, M Sonderup, A Bryer, A Corrigall, P Meissner, J M Heckmann.   

Abstract

Acute intermittent porphyria, the most common porphyria affecting the nervous system, typically presents with neurovisceral crises followed by a motor neuropathy. We describe a 23-year-old black South African man presenting with a progressive stuttering, lower motor neuron syndrome developing over months. He had not experienced pain or neuropsychiatric symptoms. One year after symptom onset he was bed-bound with a flaccid quadriparesis. There was marked amyotrophy, but without fasciculations. Sensation was intact apart from a hypo-aesthetic patch over the thigh. Electrophysiological investigations showed an active motor axonopathy. Urinary porphyrins, delta-aminolaevulinic acid and porphobilinogen were elevated. Mutation analysis revealed the c445C>T (R149X) mutation in the porphobilinogen deaminase gene. The patient responded dramatically to haem arginate and could walk with assistance 2 weeks later. We identified the first molecularly confirmed acute intermittent porphyria in a black South African. The clinical presentation mimicked a progressive lower motor neuron syndrome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25118551     DOI: 10.7196/samj.7785

Source DB:  PubMed          Journal:  S Afr Med J


  2 in total

1.  Muscle atrophy induced by overexpression of ALAS2 is related to muscle mitochondrial dysfunction.

Authors:  Yahui Peng; Jihong Li; Dixian Luo; Shuai Zhang; Sijia Li; Dayong Wang; Xidi Wang; Zhujun Zhang; Xue Wang; Changhui Sun; Xu Gao; Yang Hui; Rongzhang He
Journal:  Skelet Muscle       Date:  2021-03-30       Impact factor: 4.912

Review 2.  A review of the genetic spectrum of hereditary spastic paraplegias, inherited neuropathies and spinal muscular atrophies in Africans.

Authors:  Amokelani C Mahungu; Nomakhosazana Monnakgotla; Melissa Nel; Jeannine M Heckmann
Journal:  Orphanet J Rare Dis       Date:  2022-03-24       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.